tirzepatide dosing for diabetes SURPASS-2 (NEJM 2021) was the definitive head-to-head: vs semaglutide 1.0 mg (the maximum approved T2DM dose) in 1,879 patients with type 2 diabetes. All three tirzepatide doses produced superior HbA1c reductions Microdosing tirzepatide chart: complete week-by-week

EMA Decision P/0336/2024 Paediatric Investigation Plan for retatrutide

If you are researching thyroid-related concerns with weight loss peptides, our peptide safety and risks guide provides broader context for evaluating these considerations

That is an awkward number

Pantalone, DO, ECNU, FACE, professor of medicine at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, director of diabetes initiatives and staff endocrinologist in the department of endocrinology at Cleveland Clinic, told Healio | Endocrine Today

Medications requiring dose reduction, not avoidance Several medication classes require dose adjustments when starting Wegovy, but are not contraindicated

Temporary fatigue, headaches, or digestive discomfort can also occur in sensitive individuals